Abstract
The high mortality of gastric cancer (GC) is largely due to late diagnosis, and a reliable non-invasive detection method is lacking. While existing tumour markers have low sensitivity, routine blood tests (RBTs) like CBC and LRFT can indicate hidden cancer through signs of anaemia, inflammation, and cachexia. The HKUST, HA clinical team (oncology, medicine, surgery, neurosurgery), and HADCL co-developed the RBT-GC model, which can detect GC up to 6 months prior to clinical diagnosis. Previously presented at ASCO 2023 and ESMO GI 2024, this study aims to validate RBT-GC's sensitivity in a hospital setting up to 6 months before the diagnosis date.
| Original language | English |
|---|---|
| Publication status | Accepted/In press - Mar 2025 |
| Event | Hospital Authority Convention 2025 - Duration: 1 Mar 2025 → 1 Mar 2025 |
Conference
| Conference | Hospital Authority Convention 2025 |
|---|---|
| Period | 1/03/25 → 1/03/25 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Gastric Cancer Early Detection Using Routine Blood Tests and Artificial Intelligence: Validation Study at Queen Elizabeth Hospital'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver